Join
Live feed
·
PRReleasevia Quantisnow
Mallinckrodt plc logo

Keenova Advances Podiatry Pipeline with First Patient Dosed in Phase 3 Trial of XIAFLEX® (collagenase clostridium histolyticum) for Hammer Toe

ByQuantisnow·Wall Street's wire, on your screen.
MNK· Mallinckrodt plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MNK (Mallinckrodt plc) and more on Quantisnow.